Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells-Reference-Cited by-同舟云学术

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells

Published:2008-05-29 Issue:7 Volume:29 Page:1448-1458
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:Carcinogenesis

Author:

Ko J.-C.,Ciou S.-C.,Cheng C.-M.,Wang L.-H.,Hong J.-H.,Jheng M.-Y.,Ling S.-T.,Lin Y.-W.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/29/7/1448/7516620/bgn130.pdf

Reference74 articles.

1. Cancer statistics, 1999

2. American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

4. Epidermal growth factor-related peptides and their receptors in human malignancies

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rad51 Silencing with siRNA Delivered by Porous Silicon-Based Microparticle Enhances the Anti-Cancer Effect of Doxorubicin in Triple-Negative Breast Cancer;Journal of Biomedical Nanotechnology;2021-12-01

2. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer;Pharmaceuticals;2021-06-18

3. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC);Experimental and Molecular Pathology;2020-02

4. ShRNA‐mediated matrix metalloproteinase‐2 gene silencing protects normal cells and sensitizes cancer cells against ionizing‐radiation induced damage;Journal of Cellular Biochemistry;2019-09-06

5. Impaired DNA double‐strand breaks repair by kinesin family member 4A inhibition renders human H1299 non‐small‐cell lung cancer cells sensitive to cisplatin;Journal of Cellular Physiology;2018-11-11